Dr. Groteluschen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1726 Shawano Ave
Green Bay, WI 54303Phone+1 920-884-3135Fax+1 920-884-3144
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2004 - 2006
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2001 - 2004
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2001
Certifications & Licensure
- MI State Medical License 2006 - 2025
- WI State Medical License 2002 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 2 citationsA Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805]).Roberto Pili, Opeyemi Jegede, Michael A. Carducci, Judith Manola, David L. Groteluschen
Clinical Genitourinary Cancer. 2017-12-01 - 3 citationsNational Institute on Aging /Alzheimer's Association criteria for Mild Cognitive Impairment applied to chemotherapy treated breast cancer survivors.Abigail R Gifford, Julia Lawrence, Laura D. Baker, Ernie P. Balcueva, Doug Case
Journal of Oncology Research. 2017-01-01 - 7 citationsA phase II study of sorafenib, oxaliplatin, and 2 days of high-dose capecitabine in advanced pancreas cancer.Rory Joseph Makielski, Sam J. Lubner, Daniel Mulkerin, Anne M. Traynor, David Groteluschen
Cancer Chemotherapy and Pharmacology. 2015-06-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: